Danielle M Nash1, Sebastian Przech2, Ron Wald3, Daria O'Reilly4. 1. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, London Health Sciences Centre, London, Ontario, Canada. Electronic address: danielle.nash@lhsc.on.ca. 2. Department of Medicine, London Health Sciences Centre, London, Ontario, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. Electronic address: sebastian.przech@mail.mcgill.ca. 3. Department of Medicine (Nephrology), St. Michael's Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: waldr@smh.ca. 4. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Programs for Assessment of Technology in Health, St. Josephs' Healthcare Hamilton, Hamilton, Ontario, Canada. Electronic address: oreilld@mcmaster.ca.
Abstract
PURPOSE: To compare clinical outcomes among critically ill adults with acute kidney injury (AKI) treated with continuous renal replacement therapy (CRRT), intermittent hemodialysis (IHD) or sustained low efficiency dialysis (SLED). MATERIALS AND METHODS: We completed a systematic review and meta-analysis of studies published in 2015 or earlier using MEDLINE®, EMBASE®, Cochrane databases and grey literature. Eligible studies included randomized clinical trials (RCTs) or prospective cohort studies comparing outcomes of mortality, dialysis dependence or length of stay among critically ill adults receiving CRRT, IHD or SLED to treat AKI. Mortality and dialysis dependence from RCTs were pooled using meta-analytic techniques. Length of stay from RCTs and results from prospective cohort studies were described qualitatively. RESULTS: Twenty-one studies were eligible. RRT modality was not associated with in-hospital mortality (CRRT vs IHD: RR 1.00 [95% CI, 0.92-1.09], CRRT vs SLED: RR 1.23 [95% CI, 1.00-1.51]) or dialysis dependence (CRRT vs IHD: RR 0.90 [95% CI, 0.59-1.38], CRRT vs SLED: RR 1.15 [95% CI, 0.67-1.99]). CONCLUSIONS: We did not find a definitive advantage for any RRT modality on short-term patient or kidney survival. Well-designed, adequately-powered trials are needed to better define the role of RRT modalities for treatment of critically ill patients with AKI.
PURPOSE: To compare clinical outcomes among critically ill adults with acute kidney injury (AKI) treated with continuous renal replacement therapy (CRRT), intermittent hemodialysis (IHD) or sustained low efficiency dialysis (SLED). MATERIALS AND METHODS: We completed a systematic review and meta-analysis of studies published in 2015 or earlier using MEDLINE®, EMBASE®, Cochrane databases and grey literature. Eligible studies included randomized clinical trials (RCTs) or prospective cohort studies comparing outcomes of mortality, dialysis dependence or length of stay among critically ill adults receiving CRRT, IHD or SLED to treat AKI. Mortality and dialysis dependence from RCTs were pooled using meta-analytic techniques. Length of stay from RCTs and results from prospective cohort studies were described qualitatively. RESULTS: Twenty-one studies were eligible. RRT modality was not associated with in-hospital mortality (CRRT vs IHD: RR 1.00 [95% CI, 0.92-1.09], CRRT vs SLED: RR 1.23 [95% CI, 1.00-1.51]) or dialysis dependence (CRRT vs IHD: RR 0.90 [95% CI, 0.59-1.38], CRRT vs SLED: RR 1.15 [95% CI, 0.67-1.99]). CONCLUSIONS: We did not find a definitive advantage for any RRT modality on short-term patient or kidney survival. Well-designed, adequately-powered trials are needed to better define the role of RRT modalities for treatment of critically ill patients with AKI.
Authors: Alireza Shirazian; Andres F Peralta-Cuervo; Maria P Aguilera-Pena; Louis Cannizzaro; Vi Tran; Doan Nguyen; Ifeanyi Iwuchukwu Journal: Neurocrit Care Date: 2021-01-05 Impact factor: 3.210
Authors: Christian Nusshag; Markus A Weigand; Martin Zeier; Christian Morath; Thorsten Brenner Journal: Int J Mol Sci Date: 2017-06-28 Impact factor: 5.923
Authors: Zhikang Ye; Ying Wang; Long Ge; Gordon H Guyatt; David Collister; Waleed Alhazzani; Sean M Bagshaw; Emilie P Belley-Cote; Fang Fang; Liangying Hou; Philipp Kolb; Francois Lamontagne; Simon Oczkowski; Lonnie Pyne; Christian Rabbat; Matt Scaum; Borna Tadayon Najafabadi; Wimonchat Tangamornsuksan; Ron Wald; Qi Wang; Michael Walsh; Liang Yao; Linan Zeng; Abdullah Mohammed Algarni; Rachel J Couban; Paul Elias Alexander; Bram Rochwerg Journal: Crit Care Explor Date: 2021-05-12
Authors: Kevin K Chung; Elsa C Coates; William L Hickerson; Angela L Arnold-Ross; Daniel M Caruso; Marlene Albrecht; Brett D Arnoldo; Christina Howard; Laura S Johnson; Melissa M McLawhorn; Bruce Friedman; Amy M Sprague; Michael J Mosier; David J Smith; Rachel A Karlnoski; James K Aden; Elizabeth A Mann-Salinas; Steven E Wolf Journal: J Burn Care Res Date: 2018-10-23 Impact factor: 1.845
Authors: Chandan Vangala; Maulin Shah; Natasha N Dave; Layth Al Attar; Sankar D Navaneethan; Venkat Ramanathan; Susan Crowley; Wolfgang C Winkelmayer Journal: Ren Fail Date: 2021-12 Impact factor: 2.606